NIH licenses TheraDoc clinical solutions

The Clinical Center of the National Institutes of Health Clinical Center has joined a roster of hospitals and healthcare systems in the U.S. that has licensed the clinical solutions developed by TheraDoc (Salt Lake City). The NIH CC and TheraDoc will implement knowledge modules designed to provide advanced tools for active infection surveillance, antimicrobial stewardship, adverse drug event monitoring and documentation, and critical care at the 250-bed treatment and research hospital.

The TheraDoc expert system will provide an interface through which context-specific clinical data will be evaluated, confirmed and acted upon. It will combine patient- and disease-specific data with best-practice guidelines. It will also translate the data into actionable patient information, and push it securely to clinicians in real-time.

TheraDoc is a clinical informatics company.

Response to move headquarters

Response Biomedical (Vancouver) said that it plans to move to its new global headquarters located at 1781 - 75th Avenue West, Vancouver, British Columbia on March 31.

The 46,000-square-foot, single-occupant, specialized-use facility was designed and constructed for development and GMP manufacturing and distribution of point-of-care (POC) medical diagnostic test kits.

Response makes rapid point-of-care tests for use with its portable RAMP platform for clinical and environmental applications.

Solis-BenOra relocates

Solis-BenOra Imaging (Phoenix, Arizona) reported that it has relocated to 1313 E. Osborn Road in Phoenix. The new 8600 square foot facility features digital mammography technology for screening and diagnostic studies and will continue to offer breast and general ultrasound, bone densitometry, and ultrasound and stereotactic biopsies.

The company was formed by the merger in early January of BenOra Imaging with Solis Women's Health, focused on the screening/diagnosis of breast cancer.